Sanket Shah, Angel Investor

Sanket Shah is a seasoned professional with global outcomes, research, and health economics experience in the pharmaceutical sector. He's recognized for demonstrating a natural aptitude for performing rigorous research to influence high-level decision-making, as well as for engaging with global stakeholders and spearheading product value strategy. He's the current Director of Global Value & HEOR at Jazz Pharmaceuticals, supporting pipeline market access planning, value enhancement through clinical development, and rigorous HEOR/RWE planning for late-stage asset commercialization. He was a former Head of US HEOR Strategy at Novo Nordisk and a former Peer Reviewer at the Journal of Managed Care and Specialty Pharmacy. As early as 2021, he has also been an angel investor in various startups with a strong focus on the medical industry.